Literature DB >> 10159004

The cost of diabetic neuropathy.

J D Ward1.   

Abstract

Little information is available as to the exact financial cost of the clinical features of diabetic neuropathy. At least 20% of diabetic patients have a neuropathic problem consisting of either sensory pain and discomfort, foot ulceration or impotence. This represents a large load of clinical work in any diabetes service. Such patients should be offered thorough and sympathetic clinical facilities, from careful diagnosis and assessment through to treatment and counselling, to allow them to accept, and hopefully obtain improvement in, what is essentially an incurable clinical situation. Similarly, the emotional and financial costs to the patients of such a chronic condition have not been adequately assessed. It seems reasonable to suggest that such costs are high, and it is a general impression that patients with this problem do not receive adequate time and attention in many busy diabetes services.

Entities:  

Mesh:

Year:  1995        PMID: 10159004     DOI: 10.2165/00019053-199500081-00011

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  14 in total

1.  Cardiorespiratory arrest and diabetic autonomic neuropathy.

Authors:  M M Page; P J Watkins
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

2.  Intracavernous injection of prostaglandin E1 in impotent men.

Authors:  W Stackl; R Hasun; M Marberger
Journal:  J Urol       Date:  1988-07       Impact factor: 7.450

3.  Impotence in diabetes: aetiology, implications for treatment and preferred vacuum device.

Authors:  R E Ryder; C F Close; K T Moriarty; K T Moore; C A Hardisty
Journal:  Diabet Med       Date:  1992-12       Impact factor: 4.359

4.  The natural history of painful diabetic neuropathy--a 4-year study.

Authors:  A J Boulton; W D Armstrong; J H Scarpello; J D Ward
Journal:  Postgrad Med J       Date:  1983-09       Impact factor: 2.401

Review 5.  Detection, characterization, and staging of polyneuropathy: assessed in diabetics.

Authors:  P J Dyck
Journal:  Muscle Nerve       Date:  1988-01       Impact factor: 3.217

6.  A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.

Authors:  M J Young; A J Boulton; A F MacLeod; D R Williams; P H Sonksen
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

7.  The natural history of diabetic autonomic neuropathy.

Authors:  D J Ewing; I W Campbell; B F Clarke
Journal:  Q J Med       Date:  1980

8.  Mortality in diabetic patients with cardiovascular autonomic neuropathy.

Authors:  W Rathmann; D Ziegler; M Jahnke; B Haastert; F A Gries
Journal:  Diabet Med       Date:  1993-11       Impact factor: 4.359

9.  Hospital admissions of diabetic patients: information from hospital activity analysis.

Authors:  D R Williams
Journal:  Diabet Med       Date:  1985-01       Impact factor: 4.359

10.  Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy.

Authors:  A J Boulton; C A Hardisty; R P Betts; C I Franks; R C Worth; J D Ward; T Duckworth
Journal:  Diabetes Care       Date:  1983 Jan-Feb       Impact factor: 19.112

View more
  1 in total

1.  Assessing the impact of complications on the costs of Type II diabetes.

Authors:  R Williams; L Van Gaal; C Lucioni
Journal:  Diabetologia       Date:  2002-07       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.